Oscar Health (OSCR) director David Plouffe receives 681 deferred stock units as fee

Rhea-AI Filing Summary

Plouffe David reported acquisition or exercise transactions in this Form 4 filing.

Oscar Health, Inc. director David Plouffe received a grant of 681 deferred stock units on July 9, 2026 as board compensation. Each unit represents a right to receive one share of Class A common stock and was valued using the Class A closing price of $31.20 on that date.

The units were issued under the Amended and Restated Deferred Compensation Plan for Directors in lieu of cash retainer payments and are 100% vested on the grant date. They will be settled in cash or Class A shares, at the company’s discretion, within 45 days after specified events such as termination of service, a change in control, death, or disability. Following this grant, Plouffe holds 7,535 deferred stock units directly.

Filing Explained

A director received 681 vested deferred units instead of cash; they may later settle in cash or shares, with no current share issuance disclosed.

A Form 4 reports an insider transaction, and the July 13, 2026 filing records a director of Oscar Health receiving 681 deferred stock units on July 9, 2026 in lieu of a cash board-retainer payment.

The transaction is an award, identified by code A, rather than a reported sale, purchase, or current issuance of Class A common stock. Each deferred stock unit represents a right to receive one share of Class A common stock.

The units are 100% vested on the grant date, but the issuer may settle them in cash or shares within 45 days after the first of specified events, including termination of service, a change in control, death, or disability.

The director's disclosed derivative holdings after the award are 7,535 units. The reported $31.2 price is the July 9 closing price used to calculate the units, not a disclosed cash payment for them.

Accordingly, the filing records deferred compensation rather than shares issued today; delivery of Class A shares remains a possible future settlement, while the filing does not establish that such delivery will occur.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Plouffe David

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Deferred Stock Unit F1, F3, F2	681	$31.20	$21K

Holdings After Transaction: Deferred Stock Unit — 7,535 shares (Direct)

Footnotes (3)

1. F1. Each deferred stock unit represents a right to receive one share of the Issuer's Class A common stock.
2. F2. The deferred stock units will be settled for cash or shares of Class A common stock, in the Issuer's discretion, within 45 days of the first to occur of (i) termination of service; (ii) a change in control; (iii) death; or (iv) disability. Deferred stock units issued in lieu of a cash retainer payment are 100% vested on the grant date.
3. F3. The Reporting Person elected, pursuant to the Issuer's Amended and Restated Deferred Compensation Plan for Directors, to receive deferred stock units in lieu of cash retainer payments for service on the Issuer's board of directors. The price of the deferred stock units reported herein represents the closing price of the Issuer's Class A common stock on July 9, 2026, which price was used to calculate the number of deferred stock units issued to the Reporting Person.

Key Figures

Deferred stock units granted: 681 units Reference share price: $31.20 Deferred stock units after grant: 7,535 units +1 more

4 metrics

Deferred stock units granted 681 units Grant of deferred stock units on July 9, 2026

Reference share price $31.20 Closing price of Class A common stock on July 9, 2026 used to calculate units

Deferred stock units after grant 7,535 units Total deferred stock units held directly by David Plouffe after transaction

Settlement window 45 days Units settled within 45 days after specified triggering event

Key Terms

Deferred Stock Unit, change in control, Amended and Restated Deferred Compensation Plan for Directors

3 terms

Deferred Stock Unit financial

"Each deferred stock unit represents a right to receive one share"

A deferred stock unit (DSU) is a promise from a company to give an employee or director the value of a share at a future date, paid in actual shares or cash when certain conditions are met (such as retirement or a set date). Think of it like a gift card that converts to company stock later; it aligns pay with long‑term performance and can affect future share count, compensation expense and potential cash needs, so investors watch DSUs for their impact on dilution and company finances.

change in control financial

"within 45 days of the first to occur of (i) termination of service; (ii) a change in control"

A "change in control" occurs when the ownership or management of a company shifts significantly, such as through a merger, acquisition, or sale of a large part of its assets. This change can impact how the company is run and may influence its future direction. For investors, it matters because it can affect the company's stability, strategy, and value, often signaling potential changes in investment risk or opportunity.

Amended and Restated Deferred Compensation Plan for Directors financial

"pursuant to the Issuer's Amended and Restated Deferred Compensation Plan for Directors"

FAQ

What did Oscar Health (OSCR) director David Plouffe report on this Form 4?

David Plouffe reported the grant of 681 deferred stock units tied to Oscar Health Class A common stock on July 9, 2026. These units were received as board compensation in lieu of a cash retainer payment and are 100% vested on the grant date.

How many Oscar Health (OSCR) deferred stock units does David Plouffe hold after this transaction?

After the July 9, 2026 grant, David Plouffe holds 7,535 deferred stock units directly. Each deferred stock unit represents a right to receive one share of Oscar Health’s Class A common stock, subject to the plan’s settlement terms.

What is a deferred stock unit in the context of Oscar Health (OSCR)?

For Oscar Health, each deferred stock unit gives the holder a right to receive one share of Class A common stock. Settlement occurs in cash or shares, at the company’s discretion, after specified events like termination of service or a change in control.

At what price were David Plouffe’s Oscar Health (OSCR) deferred stock units valued?

The 681 deferred stock units were valued using the $31.20 closing price of Oscar Health’s Class A common stock on July 9, 2026. That price was used solely to calculate the number of units issued as compensation.

When will David Plouffe’s Oscar Health (OSCR) deferred stock units be settled?

The deferred stock units will be settled for cash or Class A shares, at Oscar Health’s discretion, within 45 days after the first of several events, including termination of service, change in control, death, or disability.

Why did David Plouffe receive Oscar Health (OSCR) deferred stock units instead of cash?

David Plouffe elected, under Oscar Health’s Amended and Restated Deferred Compensation Plan for Directors, to receive deferred stock units in lieu of cash retainer payments for his board service. This election converts his cash compensation into equity-linked units.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 07/13/2026 - 04:15 PM Accepted by SEC EDGAR 07/13/2026 - 04:14 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Plouffe David

(Last) (First) (Middle)

75 VARICK STREET, 5TH FLOOR

(Street)

NEW YORK NEW YORK 10013

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Oscar Health, Inc. [ OSCR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/09/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Deferred Stock Unit	(1)	07/09/2026		A		681		(2)	(2)	Class A Common Stock	681	$31.2(3)	7,535	D

Explanation of Responses:

1. Each deferred stock unit represents a right to receive one share of the Issuer's Class A common stock.

2. The deferred stock units will be settled for cash or shares of Class A common stock, in the Issuer's discretion, within 45 days of the first to occur of (i) termination of service; (ii) a change in control; (iii) death; or (iv) disability. Deferred stock units issued in lieu of a cash retainer payment are 100% vested on the grant date.

3. The Reporting Person elected, pursuant to the Issuer's Amended and Restated Deferred Compensation Plan for Directors, to receive deferred stock units in lieu of cash retainer payments for service on the Issuer's board of directors. The price of the deferred stock units reported herein represents the closing price of the Issuer's Class A common stock on July 9, 2026, which price was used to calculate the number of deferred stock units issued to the Reporting Person.

Remarks:

	/s/ Melissa Curtin, Attorney-in-fact	07/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)